RDC Medical and Scientific Affairs
Past Live Events
September 16, 2020
Wed 12:00 PM EDT
Wed 12:00 PM EDT
Web
Sept Event - Scoring PD-L1 in Triple Negative Breast Cancer using the FDA-approved Ventana PD-L1 (SP142) assay
A live webcast training course designed for pathologists and lab personnel interested in learning how to score and implement the PD-L1 biomarker test in TNBC with the...
May 29, 2019
Wed 2:00 PM EDT
Wed 2:00 PM EDT
Web
Recording of: Scoring PD-L1 in TNBC with the Ventana SP142 Assay
Ventana PD-L1 (SP142) IHC Assay is the first and only PD-L1 test that is FDA approved for Triple Negative Breast Carcinoma (TNBC). Roche Medical Affairs Pathologists...